Authors

Sergio Gonzalez-Arias, Miami Neuroscience InstituteFollow

Combined BH3 and Metabolic Profiling as a Method to Define Therapeutic Response and Resistance in Grade IB Astrocytomas

Publication Date

11-2015

Presented At:

Society for Neuro-Oncology Annual Scientific Meeting

Content Type

Presentation

Additional Authors:

Additional authors and institutional affiliations

Citation

Gonzalez-Arias, Sergio, "Combined BH3 and Metabolic Profiling as a Method to Define Therapeutic Response and Resistance in Grade IB Astrocytomas" (2015). All Publications. 2867.
https://scholarlycommons.baptisthealth.net/se-all-publications/2867